cGAMP biomarker analysis in ALS patient spinal cord samples

Clinical Score: 0.850 Price: $0.50 amyotrophic lateral sclerosis human patients Status: proposed

What This Experiment Tests

Clinical experiment designed to assess clinical efficacy targeting N/A in human patients. Primary outcome: cGAMP levels in spinal cord tissue

Description

Analysis of spinal cord tissue samples from ALS" class="entity-link entity-disease" title="disease: ALS">ALS patients to measure levels of cyclic GMP-AMP (cGAMP), the specific metabolite produced by cGAS activation. This study aimed to validate the clinical relevance of cGAS/STING pathway activation in human ALS and establish cGAMP as a potential biomarker for mitochondrial DNA release and innate immune activation in ALS patients.

TARGET GENE
N/A
MODEL SYSTEM
human patients
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
cGAS/STING innate immune signaling
SOURCE
extracted_from_pmid_33031745
PRIMARY OUTCOME
cGAMP levels in spinal cord tissue

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

STING Inhibitor Therapy in NeurodegenerationtherapeuticDNA Repair Therapy for NeurodegenerationtherapeuticDNA Damage Repair Therapy for NeurodegenerationtherapeuticALS Treatment StrategiestherapeuticALS Treatment OverviewtherapeuticALS TherapeuticstherapeuticALS Therapeutic Landscape — Programs by Phase and diseaseALS Cure RoadmaptherapeuticALS Communication Brain-Computer InterfacestechnologySTING ProteinproteinSTING ProteinredirectDNA-PKcs (PRKDC) ProteinproteinDNA Ligase IV ProteinproteinDNA Ligase III ProteinproteinSTING-CASM-GABARAP-LRRK2 Pathway in Parkinson's Dimechanism

Protocol

Measurement of cGAMP metabolite levels in post-mortem spinal cord samples from ALS" class="entity-link entity-disease" title="disease: ALS">ALS patients compared to controls

Expected Outcomes

Elevated cGAMP levels in ALS" class="entity-link entity-disease" title="disease: ALS">ALS patient spinal cord samples

Success Criteria

Significantly higher cGAMP levels in ALS" class="entity-link entity-disease" title="disease: ALS">ALS patients versus controls

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.